Atyr Pharma Inc Revenue per Employee (ATYR), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Atyr Pharma Inc   (NASDAQ: ATYR)
 

Atyr Pharma Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Atyr Pharma Inc 's Revenue per employee fell on a trailing twelve month basis to $ 3,276, but the productivity of Atyr Pharma Inc 's employees remained above the company average.
Within the Healthcare sector Atyr Pharma Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Atyr Pharma Inc has 58 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ATYR Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 3,276 3,276 3,276 3,276 -
ATYR's Total Ranking # # # # #
Seq. Revenue Change - - - - -

ATYR Company Profile >> Back to ATYR Efficiency Comparisons >> Compare ATYR Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 180,259 $ 155,474 $ 146,328
(Dec 31 2020)   (Mar 31 2020)



Financial Statements
Atyr Pharma Inc 's Revenue MRQ $ 0 Millions Visit ATYR's Income Statement
Atyr Pharma Inc 's Revenues TTM $ 0 Millions Visit ATYR's aggregate revenue growth
What are ATYR's Sales? Visit ATYR's Sales by Segment


  News about Atyr Pharma Inc Revenue per employee

aTyr Pharma Strengthens Position in Anti-Fibrotic Research and Oncology with Key Appointments and Promising Therapeutics for Fibrotic Diseases and GBM

In recent months, aTyr Pharma has made significant strides in the development of innovative therapies for complex medical conditions, highlighting its commitment to enhancing treatment outcomes for patients. Central to this momentum is the appointment of Dalia R. Rayes as the Head of Commercial for the Global Efzofitimod Franchise, reflecting a strategic focus on accelerating market penetration and commercial success for the company s promising therapeutics.With a background rich in commercial leadership and extensive industry experience, Rayes emerges as a critical player in aTyr’s future aspirations. Her appointment coincides with the company’s advancing pipeline and represents a pivotal point as aTyr Pharma prepares to bring novel treatments to market, particularly targeting pulmonary fibrosis and glioblastoma multiforme (GBM).



Other Ratios
Atyr Pharma Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ATYR's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ATYR's Competitors
Revenue per Employee for ATYR's Suppliers
Revenue per Employee for ATYR's Customers

You may also want to know
ATYR's Sales Growth Rates ATYR's Pe Price to earnings ratio ATYR's Receivables Turnover Ratio ATYR's Stock Quote
ATYR's Net Income Growth Rates ATYR's Ps Price to Sales ratio ATYR's Sales per Employee ATYR's Asset Turnover Ratio
ATYR's Net Margin ATYR's Pb Price to Book ratio ATYR's Financial Strength Ratios ATYR's Dividend Payout Ratio
Date modified: 2026-08-14T08:40:22+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Prokidney Corp   3,541.13 $ 0.818  Million 231 
Pavmed Inc   3,073.17 $ 0.126  Million 41 
Clene Inc   2,493.67 $ 0.197  Million 79 
Aspire Biopharma Holdings Inc   2,281.51 $ 0.103  Million 45 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.